BICKHAM JEREMIAH RAWLINS

RYAN President Bickham sold 50,000 shares ($3.5M) on 2025-05-16; now holds just 2,159 shares.

BICKHAM JEREMIAH RAWLINS divested approximately 95.9% of his position in Ryan Specialty Holdings, reducing holdings from 52,159 shares to 2,159 shares via a $3,504,705 sale at $70.09 per share. This dramatic reduction in executive stake is noteworthy given the magnitude of the position reduction and the President's role. His prior two sales at this ticker (August 2024) both resulted in positive 90-day returns (+11.4% and +9.9% respectively), indicating his past RYAN sales have not preceded declines; the current sale at $70.09 is -7.4% below the 52-week high of $75.93. The company's fundamentals show strong annual revenue growth of +21.1% but a negative net income of $-27.6M against $690.2M quarterly revenue, reflecting profitability challenges that may warrant investor attention to near-term earnings trajectory.

RYAN CFO Bickham sells 50,000 shares (97.9% of pre-transaction holdings) for $3.2M at $64.81 avg on Aug 14–15

Jeremiah Rawlins, EVP & Chief Financial Officer of Ryan Specialty Holdings, executed 2 separate sales totaling 50,000 shares for $3,240,475.50 on August 14–15, 2024, at a blended average price of $64.81. The sale represents a reduction of 97.9% of his pre-transaction holdings (from 51,078 shares to 1,078 shares). The stock's current price of $64.48 is 6.0% below the 52-week high of $68.57, and the sale occurred during a period of strong price momentum (90-day change of +19.0%). The company shows a P/E of 87.14 and annual revenue growth of +20.4%, indicating elevated valuation relative to earnings. Note: this filing involves a derivative conversion per the FLAG section; the insider's complete position includes derivative securities in Table II and should not be inferred solely from the Table I shares remaining.